19.04.2016 18:44:26
|
DGAP-News: LeenLife Pharma International Inc
DGAP-News: ARYZTA Selling Baked Goods Containing LeenLife Omega-3 Product
19.04.2016 / 18:44 The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Vancouver, British Columbia--(Newsfile Corp. - April 19, 2016) - LeenLife Pharma International Inc. (CSE: LLP) ('LeenLife' or the 'Company') is pleased to announce that after several months of testing, technological studies and satisfactory consumer acceptance, ARYZTA is now selling baked loaves of bread and rolls using LeenLife's proprietary omega-3 product in Poland. ARYZTA AG is one of the largest producers of frozen bakery products in the world. See link to omega bread: http://www.aryzta.pl/en/products-assortment-breads,s-2. The main features of LeenLife omega-3 products are:
- Can be added to bread and rolls with no separation of ingredients and no reduction in essential omega fatty acids, - Can be baked or frozen keeping a fresh flavor but with resistance to oxidation, - No fishy or oily taste, - Vegan product.
LeenLife has developed a patented process to isolate omega-3 fatty acids from flax seeds. LeenLife products have been developed and researched for over 17 years. For additional information see our website at: http://leenlifepharma.com. Bread offered by ARYZTA according to store posters state that, three slices of omega bread provide the same amount of omega-3 (equivalent) as contained in 1 kg of cod fish. The loaves of bread and rolls containing LeenLife's omega 3 product are currently being introduced to over 2,700 commercial stores in Poland.
LeenLife plans to bring its proprietary omega fatty acid products to Canada and the United States. LeenLife has developed technology to combine omega fatty acids into various food products such as bread, cheese, noodles, milk, juices and chocolate.
Stan Lis, CEO and a director of the Company, states: 'We are very excited to be a part of the growing consumer movement to provide healthy food products. Health awareness is an expanding model driving foods to new levels. Our proprietary omega products are healthy, digestible, vegan and can be an essential part of new food products.'
About LeenLife
For more information, please contact: Stan Lis, CEO Tel: 604 764-0518 E-mail: slis@leenlifepharma.com
Click on, or paste the following link into your web browser, to view the associated documents
http://www.newsfilecorp.com/release/20183
News Source: Newsfile
---------------------------------------------------------------------------
19.04.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English Company: LeenLife Pharma International Inc. Canada ISIN: CA5242751041 End of News DGAP News Service ---------------------------------------------------------------------------
455681 19.04.2016
DGAP-News: LeenLife Pharma International Inc. / Key word(s): Miscellaneous ARYZTA Selling Baked Goods Containing LeenLife Omega-3 Product
19.04.2016 / 18:44 The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Vancouver, British Columbia--(Newsfile Corp. - April 19, 2016) - LeenLife Pharma International Inc. (CSE: LLP) ('LeenLife' or the 'Company') is pleased to announce that after several months of testing, technological studies and satisfactory consumer acceptance, ARYZTA is now selling baked loaves of bread and rolls using LeenLife's proprietary omega-3 product in Poland. ARYZTA AG is one of the largest producers of frozen bakery products in the world. See link to omega bread: http://www.aryzta.pl/en/products-assortment-breads,s-2. The main features of LeenLife omega-3 products are:
- Can be added to bread and rolls with no separation of ingredients and no reduction in essential omega fatty acids, - Can be baked or frozen keeping a fresh flavor but with resistance to oxidation, - No fishy or oily taste, - Vegan product.
LeenLife has developed a patented process to isolate omega-3 fatty acids from flax seeds. LeenLife products have been developed and researched for over 17 years. For additional information see our website at: http://leenlifepharma.com. Bread offered by ARYZTA according to store posters state that, three slices of omega bread provide the same amount of omega-3 (equivalent) as contained in 1 kg of cod fish. The loaves of bread and rolls containing LeenLife's omega 3 product are currently being introduced to over 2,700 commercial stores in Poland.
LeenLife plans to bring its proprietary omega fatty acid products to Canada and the United States. LeenLife has developed technology to combine omega fatty acids into various food products such as bread, cheese, noodles, milk, juices and chocolate.
Stan Lis, CEO and a director of the Company, states: 'We are very excited to be a part of the growing consumer movement to provide healthy food products. Health awareness is an expanding model driving foods to new levels. Our proprietary omega products are healthy, digestible, vegan and can be an essential part of new food products.'
About LeenLife
For more information, please contact: Stan Lis, CEO Tel: 604 764-0518 E-mail: slis@leenlifepharma.com
Click on, or paste the following link into your web browser, to view the associated documents
http://www.newsfilecorp.com/release/20183
News Source: Newsfile
---------------------------------------------------------------------------
19.04.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English Company: LeenLife Pharma International Inc. Canada ISIN: CA5242751041 End of News DGAP News Service ---------------------------------------------------------------------------
455681 19.04.2016
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu LeenLife Pharma International Incmehr Nachrichten
Keine Nachrichten verfügbar. |